Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study

scientific article

Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2016PLoSO..1149732F
P356DOI10.1371/JOURNAL.PONE.0149732
P932PMC publication ID4769181
P698PubMed publication ID26918947
P5875ResearchGate publication ID296055724

P50authorHoward BergmanQ114769704
P2093author name stringLaure de Decker
Vanessa Pauly
Frédérique Retornaz
Anaïs Farcet
Catherine Molines
Frédérique Rousseau
P2860cites workPredictors of early death risk in older patients treated with first-line chemotherapy for cancerQ48696372
Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA studyQ48839251
Impact of an oncogeriatric consulting team on therapeutic decision-making.Q50856666
Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample.Q51930389
The development, validity, and reliability of the OARS multidimensional functional assessment questionnaireQ52101368
A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study.Q54429116
ANOREXIA AS AN INDEPENDENT PREDICTOR OF MORTALITYQ57741727
One-leg balance is an important predictor of injurious falls in older personsQ73408768
Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditionsQ74226162
Usefulness of frailty markers in the assessment of the health and functional status of older cancer patients referred for chemotherapy: a pilot studyQ81358289
Assessment for frailty is useful for predicting morbidity in elderly patients undergoing colorectal cancer resection whose comorbidities are already optimizedQ83007862
Comprehensive geriatric assessment and its clinical impact in oncologyQ83425168
Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot studyQ84161062
“Mini-mental state”Q25938989
Frailty in older adults: evidence for a phenotypeQ28205094
Frailty as a predictor of surgical outcomes in older patientsQ28283804
Phenotype of frailty: characterization in the women's health and aging studiesQ28304047
The timed "Up & Go": a test of basic functional mobility for frail elderly personsQ29615553
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentQ29615678
Toxicity and response criteria of the Eastern Cooperative Oncology GroupQ29619399
Comprehensive geriatric assessment and its clinical impact in oncologyQ33155506
The comprehensive geriatric assessment: when, where, how.Q33861566
Use of geriatric assessment for older adults in the oncology setting: a systematic review.Q34360763
Geriatric oncology: a clinical approach to the older patient with cancer.Q35111415
The frailty syndrome: a critical issue in geriatric oncologyQ35113465
Utilization of comprehensive geriatric assessment in cancer patientsQ35634086
Use of BMI in the assessment of undernutrition in older subjects: reflecting on practice.Q36209815
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).Q36220834
Aging, frailty, and chemotherapyQ36715251
Comparison of the health and functional status between older inpatients with and without cancer admitted to a geriatric/internal medicine unitQ36912037
Hand-grip dynamometry predicts future outcomes in aging adults.Q37167733
Implementing frailty into clinical practice: a cautionary tale.Q37251427
Evaluating the older patient with cancer: understanding frailty and the geriatric assessmentQ37696009
Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposalsQ37775188
Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patientsQ37796285
Frailty: a common pathway in aging and cancerQ38090445
Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily livingQ40210134
Reliability and validity of questions about exercise in the Canadian Study of Health and Aging.Q40653619
Hand grip strength: an indicator of nutritional state and the mix of postoperative complications in patients with oral and maxillofacial cancersQ40931540
Comparison of forearm muscle dynamometry with nutritional prognostic index, as a preoperative indicator in cancer patientsQ43472600
Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?Q43737974
Screening for dementia of the alzheimer type in the community: the utility of the Clock Drawing TestQ46467658
Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial.Q48422523
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)e0149732
P577publication date2016-02-26
P1433published inPLOS OneQ564954
P1476titleFrailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study
P478volume11